Dopamine D3 receptor antagonists
AssigneeIndivior UK Limited
InventorsSusanna Cremonesi, Fabrizio Micheli, Teresa Semerano, Luca Tarsi
Life of this patent
Estimating the term…
Abstract
The disclosure is directed to novel dopamine D3 receptor antagonists, processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them and their use in therapy, including treating drug dependency and psychosis.
Claims40
A compound or a pharmaceutically acceptable salt thereof, wherein the compound is:
A compound or a pharmaceutically acceptable salt thereof, wherein the compound is:
A compound or a pharmaceutically acceptable salt thereof, wherein the compound is:
A compound or a pharmaceutically acceptable salt thereof, wherein the compound is:
A compound or a pharmaceutically acceptable salt thereof, wherein the compound is:
Dependencies are inferred from the claim text.